Stereotactic Body Radiotherapy and Liver Transplant for Liver Cancer: A Nonrandomized Controlled Trial.

Autor: Lee VH; Department of Clinical Oncology, Centre of Cancer Medicine, School of Clinical Medicine, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong, China.; Department of Clinical Oncology, Queen Mary Hospital, Hong Kong, China., Vardhanabhuti V; Department of Diagnostic Radiology, School of Clinical Medicine, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong, China., Wong TC; Department of Surgery, School of Clinical Medicine, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong, China.; Department of Surgery, Queen Mary Hospital, Hong Kong, China., Lam KO; Department of Clinical Oncology, Centre of Cancer Medicine, School of Clinical Medicine, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong, China.; Department of Clinical Oncology, Queen Mary Hospital, Hong Kong, China., Choi HC; Department of Clinical Oncology, Centre of Cancer Medicine, School of Clinical Medicine, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong, China., Chiu KW; Department of Diagnostic Radiology, School of Clinical Medicine, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong, China., Ho PP; Department of Clinical Oncology, Centre of Cancer Medicine, School of Clinical Medicine, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong, China.; Department of Clinical Oncology, Queen Mary Hospital, Hong Kong, China., Leung DK; Department of Clinical Oncology, Queen Mary Hospital, Hong Kong, China., Szeto MH; Department of Clinical Oncology, Centre of Cancer Medicine, School of Clinical Medicine, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong, China.; Department of Clinical Oncology, Queen Mary Hospital, Hong Kong, China., Choi KF; Department of Clinical Oncology, Centre of Cancer Medicine, School of Clinical Medicine, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong, China.; Department of Clinical Oncology, Queen Mary Hospital, Hong Kong, China., Chan SC; Department of Surgery, School of Clinical Medicine, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong, China., Leung TW; Department of Clinical Oncology, Centre of Cancer Medicine, School of Clinical Medicine, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong, China.; Department of Clinical Oncology, Queen Mary Hospital, Hong Kong, China., Khong PL; Department of Diagnostic Radiology and Clinical Imaging Research Center, National University of Singapore, Singapore., Lo CM; Department of Surgery, School of Clinical Medicine, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong, China.; Department of Surgery, Queen Mary Hospital, Hong Kong, China.

Publikováno v: JAMA network open [JAMA Netw Open] 2024 Jun 03; Vol. 7 (6), pp. e2415998. Date of Electronic Publication: 2024 Jun 03.

Predictive factors of delayed viral clearance of asymptomatic Omicron-related COVID-19 screened positive in patients with cancer receiving active anticancer treatment.

Autor: Lee VH; Department of Clinical Oncology, School of Clinical Medicine, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China. Electronic address: vhflee@hku.hk., Chan SK; Department of Clinical Oncology, School of Clinical Medicine, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China., Tam YH; Department of Clinical Oncology, School of Clinical Medicine, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China; Department of Radiotherapy, University Hospitals of Derby and Burton NHS Foundation Trust, Derby, United Kingdom., Chau TC; Department of Clinical Oncology, School of Clinical Medicine, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China., Chan JFW; Department of Microbiology, School of Clinical Medicine, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China., Chan SY; Department of Clinical Oncology, School of Clinical Medicine, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China., Ip CY; Department of Clinical Oncology, School of Clinical Medicine, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China., Choi HC; School of Public Health, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China., Ng SC; Department of Clinical Oncology, School of Clinical Medicine, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China., Yuen KK; Department of Clinical Oncology, School of Clinical Medicine, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China.

Publikováno v: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases [Int J Infect Dis] 2023 Jul; Vol. 132, pp. 40-49. Date of Electronic Publication: 2023 Apr 16.

Overall Survival Benefits of First-Line Treatments for Asian Patients with Advanced Epidermal Growth Factor Receptor-Mutated NSCLC Harboring Exon 19 Deletion: A Systematic Review and Network Meta-Analysis.

Autor: Chan SK; Department of Clinical Oncology, School of Clinical Medicine, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong, China., Choi HC; School of Public Health, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong, China., Lee VH; Department of Clinical Oncology, School of Clinical Medicine, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong, China.

Publikováno v: Cancers [Cancers (Basel)] 2022 Jul 11; Vol. 14 (14). Date of Electronic Publication: 2022 Jul 11.

Prognostic Biomarkers for Survival in Nasopharyngeal Carcinoma: A Systematic Review of the Literature.

Autor: Islam KA; Department of Clinical Oncology, University of Hong Kong, Hong Kong, China., Chow LK; Department of Clinical Oncology, University of Hong Kong, Hong Kong, China., Kam NW; Department of Clinical Oncology, University of Hong Kong, Hong Kong, China.; Laboratory for Synthetic Chemistry and Chemical Biology, Hong Kong, China., Wang Y; Department of Radiation Oncology, Sun Yat-sen University Cancer Centre, Guangzhou 510060, China., Chiang CL; Department of Clinical Oncology, University of Hong Kong, Hong Kong, China., Choi HC; Department of Clinical Oncology, University of Hong Kong, Hong Kong, China., Xia YF; Department of Radiation Oncology, Sun Yat-sen University Cancer Centre, Guangzhou 510060, China., Lee AW; Department of Clinical Oncology, University of Hong Kong, Hong Kong, China.; Center of Clinical Oncology, University of Hong Kong-Shenzhen Hospital, Shenzhen 518009, China., Ng WT; Department of Clinical Oncology, University of Hong Kong, Hong Kong, China.; Center of Clinical Oncology, University of Hong Kong-Shenzhen Hospital, Shenzhen 518009, China., Dai W; Department of Clinical Oncology, University of Hong Kong, Hong Kong, China.; Center of Clinical Oncology, University of Hong Kong-Shenzhen Hospital, Shenzhen 518009, China.

Publikováno v: Cancers [Cancers (Basel)] 2022 Apr 24; Vol. 14 (9). Date of Electronic Publication: 2022 Apr 24.

Overall Survival Benefits of First-Line Treatments for Asian Patients With Advanced EGFR-Mutated NSCLC Harboring L858R Mutation: A Systematic Review and Network Meta-Analysis.

Autor: Chan SK; Department of Clinical Oncology, School of Clinical Medicine, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China., Choi HC; School of Public Health, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China., Lee VH; Department of Clinical Oncology, School of Clinical Medicine, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China.

Publikováno v: JTO clinical and research reports [JTO Clin Res Rep] 2022 Apr 07; Vol. 3 (5), pp. 100322. Date of Electronic Publication: 2022 Apr 07 (Print Publication: 2022).